Intuitive Surgical (ISRG) to Release Quarterly Earnings on Thursday

Intuitive Surgical (NASDAQ:ISRG) is scheduled to be issuing its quarterly earnings data after the market closes on Thursday, October 17th. Analysts expect the company to announce earnings of $1.65 per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.24. The business had revenue of $2.01 billion for the quarter, compared to analysts’ expectations of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The business’s quarterly revenue was up 14.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.18 earnings per share. On average, analysts expect Intuitive Surgical to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Intuitive Surgical Stock Down 1.9 %

Shares of Intuitive Surgical stock opened at $478.47 on Wednesday. The firm has a market capitalization of $169.71 billion, a P/E ratio of 86.37, a P/E/G ratio of 5.40 and a beta of 1.39. Intuitive Surgical has a 52 week low of $254.85 and a 52 week high of $496.48. The firm’s 50 day moving average is $481.94 and its two-hundred day moving average is $436.37.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on ISRG shares. Evercore ISI upped their price target on shares of Intuitive Surgical from $410.00 to $475.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. Barclays raised their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research report on Thursday, July 18th. Raymond James increased their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday. BTIG Research boosted their target price on shares of Intuitive Surgical from $494.00 to $518.00 and gave the stock a “buy” rating in a report on Monday. Finally, Robert W. Baird upped their target price on Intuitive Surgical from $487.00 to $503.00 and gave the company an “outperform” rating in a report on Friday, July 19th. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $467.55.

Insider Activity

In other news, EVP Robert Desantis sold 376 shares of the stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $446.60, for a total transaction of $167,921.60. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,458,979.60. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction on Monday, July 29th. The stock was sold at an average price of $446.60, for a total value of $167,921.60. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,458,979.60. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Amal M. Johnson sold 2,943 shares of Intuitive Surgical stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.90. Following the completion of the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $5,441,507.50. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 53,120 shares of company stock valued at $25,528,753 over the last quarter. Company insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.